Cervical Intraepithelial Neoplasia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: None Subjects in the efficacy analysis who received PDT in the ME2906-CIN-1 study conducted at the study site between February 2020 and February 2023 will be eligible for the study.
Exclusion criteria
Exclusion criteria: None Subjects in the efficacy analysis who received PDT in the ME2906-CIN-1 study conducted at the study site between February 2020 and February 2023 will be eligible for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of recurrence from time of PDT to time of study. | — |
Secondary
| Measure | Time frame |
|---|---|
| The period from the date of PDT in patients with no recurrence to the date of the most recent test that showed no recurrence. The period from the date of PDT for patients with recurrence to the date of the most recent examination showing no recurrence. Reasons for not obtaining data on recurrence. | — |
Contacts
Hamamatsu University School of Medicine